Belozeroff V - Search Results

1

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.

Chiroli S, Mattin C, Belozeroff V, Perrault L, Mitchell D, Gioni I. Chiroli S, et al. Among authors: belozeroff v. BMC Nephrol. 2012 Oct 29;13:140. doi: 10.1186/1471-2369-13-140. BMC Nephrol. 2012. PMID: 23106934 Free PMC article.

2

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Natoli JL, Boer R, Nathanson BH, Miller RM, Chiroli S, Goodman WG, Belozeroff V. Natoli JL, et al. Among authors: belozeroff v. BMC Nephrol. 2013 Apr 17;14:88. doi: 10.1186/1471-2369-14-88. BMC Nephrol. 2013. PMID: 23594621 Free PMC article. Review.

3

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet.

Belozeroff V, Lee A, Tseng S, Chiroli S, Campbell JD. Belozeroff V, et al. J Med Econ. 2013 Sep;16(9):1154-62. doi: 10.3111/13696998.2013.826665. Epub 2013 Aug 6. J Med Econ. 2013. PMID: 23869940 Free article. Clinical Trial.

4

Hemodialysis patients' preferences for the management of secondary hyperparathyroidism.

Hauber B, Caloyeras J, Posner J, Brommage D, Belozeroff V, Cooper K. Hauber B, et al. Among authors: belozeroff v. BMC Nephrol. 2017 Jul 28;18(1):254. doi: 10.1186/s12882-017-0665-8. BMC Nephrol. 2017. PMID: 28750605 Free PMC article.

5

Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.

Danese MD, Lubeck D, Belozeroff V, Lin TC, Desai P, Gleeson M, Martin K, Chonchol M. Danese MD, et al. Among authors: belozeroff v. Am J Nephrol. 2020;51(10):815-822. doi: 10.1159/000510360. Epub 2020 Sep 23. Am J Nephrol. 2020. PMID: 32966995

6

Association of cinacalcet adherence and costs in patients on dialysis.

Lee A, Song X, Khan I, Belozeroff V, Goodman W, Fulcher N, Diakun D. Lee A, et al. Among authors: belozeroff v. J Med Econ. 2011;14(6):798-804. doi: 10.3111/13696998.2011.627404. Epub 2011 Oct 11. J Med Econ. 2011. PMID: 21988567 Free article.

7

Healthcare use and costs before and after parathyroidectomy in patients on dialysis.

Belozeroff V, Cooper K, Hess G, Chang CL. Belozeroff V, et al. BMC Health Serv Res. 2013 Jul 2;13:248. doi: 10.1186/1472-6963-13-248. BMC Health Serv Res. 2013. PMID: 23819622 Free PMC article.

8

Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis.

Davies EW, Matza LS, Worth G, Feeny DH, Kostelec J, Soroka S, Mendelssohn D, McFarlane P, Belozeroff V. Davies EW, et al. Among authors: belozeroff v. Health Qual Life Outcomes. 2015 Jun 30;13:90. doi: 10.1186/s12955-015-0266-9. Health Qual Life Outcomes. 2015. PMID: 26122041 Free PMC article.

9

Consistent control of mineral and bone disorder in incident hemodialysis patients.

Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Danese MD, et al. Among authors: belozeroff v. Clin J Am Soc Nephrol. 2008 Sep;3(5):1423-9. doi: 10.2215/CJN.01060308. Epub 2008 Jul 2. Clin J Am Soc Nephrol. 2008. PMID: 18596117 Free PMC article.

10

Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy.

Stollenwerk B, Iannazzo S, Cooper K, Belozeroff V. Stollenwerk B, et al. Among authors: belozeroff v. J Med Econ. 2017 Oct;20(10):1110-1115. doi: 10.1080/13696998.2017.1360309. Epub 2017 Aug 14. J Med Econ. 2017. PMID: 28803497 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters